PM
Prosight Management Portfolio holdings
AUM
$410M
1-Year Return
14.96%
This Quarter Return
-1.43%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
–
AUM
$203M
AUM Growth
+$1.2M
(+0.6%)
Cap. Flow
-$7.15M
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
50.42%
Holding
59
New
11
Increased
16
Reduced
17
Closed
14
Top Buys
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$7.41M |
| 2 |
Baxter International
BAX
|
$6.39M |
| 3 |
Cue Biopharma
CUE
|
$6.01M |
| 4 |
Prothena Corp
PRTA
|
$5.45M |
| 5 |
MTCR
Metacrine, Inc. Common Stock
MTCR
|
$5.3M |
Top Sells
| 1 |
Kura Oncology
KURA
|
$17.7M |
| 2 |
Arrowhead Research
ARWR
|
$4.93M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$4.8M |
| 4 |
Aldeyra Therapeutics
ALDX
|
$3.91M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$3.11M |
Sector Composition
| 1 | Healthcare | 92.16% |
| 2 | Technology | 4.47% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
51
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – |
-25,602
| Closed | -$1.65M |
|
|
MGLN
52
DELISTED
Magellan Health Services, Inc.
MGLN
| – | – |
-5,200
| Closed | -$379K |
|
53
AMN Healthcare
AMN
$760M
| – | – |
-26,851
| Closed | -$1.22M |
|
|
54
Arrowhead Research
ARWR
$3.84B
| – | – |
-114,100
| Closed | -$4.93M |
|
55
Evolus
EOLS
$473M
| – | – |
-281,541
| Closed | -$1.49M |
|
56
Immunovant
IMVT
$2.87B
| – | – |
-95,500
| Closed | -$2.33M |
|
|
MODV
57
DELISTED
ModivCare
MODV
| – | – |
-14,923
| Closed | -$1.18M |
|
58
NeoGenomics
NEO
$1.03B
| – | – |
-38,819
| Closed | -$1.2M |
|
59
Personalis
PSNL
$445M
| – | – |
-188,750
| Closed | -$2.45M |
|